KYNMOBI

sunovion pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 64a381847f3ce696
Drug Approval Canada Name: KYNMOBI
Product Name: KYNMOBI
Status: Cancelled Post Market
Status Date: 2023-09-29
Original Market Date: 2020-11-17
Din: 02500299
Drug Class: Human
Dosage Form: Film, Soluble
Route Of Administration: Sublingual
Schedule: Prescription
Ahfs: 28:36.20.08
Atc Original: N04BC07 APOMORPHINE
Atc Name: n 04 bc 07
Aig Number: 0158570004
Company Name: sunovion pharmaceuticals canada inc
Company Address: 7025 Langer Drive, Suite 301, Mississauga, Ontario, Canada, L5N 0E8

APOMORPHINE HYDROCHLORIDE

25 MG / FILM

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

64a381847f3ce696

Type

Standard